PTK2 and neoplasm: FAK/PTK2 activity is significantly increased in tumor groups of CHOL, COAD, HNSC, LIHC, LUAD, LUSC, and STAD, and is decreased in tumor groups of KIRC, KIRP, THCA, and UCEC (Fig. 3A).